
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ZnT-5 CRISPR/Cas9 KO Plasmid (h) | sc-404516 | 20 µg | $397.00 | |||
ZnT-5 HDR Plasmid (h) | sc-404516-HDR | 20 µg | $445.00 |
SLC30A5 encodes the zinc transporter ZnT-5, a multi-pass membrane protein that supports zinc loading into the secretory pathway, contributing to zinc-dependent maturation and activity of Golgi/ER client proteins. By regulating subcellular zinc distribution, ZnT-5 influences metalloprotein function, redox balance, and signaling processes sensitive to zinc availability, including pathways that rely on properly metallated enzymes. Altered zinc homeostasis and disrupted ZnT family transporter activity have been linked to phenotypes involving impaired secretory protein processing and broader cellular stress responses, providing disease-relevant context for studying ZnT-5 function in human cells.
ZnT-5 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SLC30A5 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the SLC30A5 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, ZnT-5 HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined SLC30A5 target site.
When co-transfected with ZnT-5 CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the SLC30A5 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.